John R Cashman

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Induced Apoptosis

Radical Prostatectomy

Top Venues

Investigational new drugs

Drug metabolism and disposition: the biological fate of chemicals

Journal of medicinal chemistry

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

John R Cashman, Emily A Cashman
Effect of PAWI-2 on pancreatic cancer stem cell tumors. Investigational new drugs 42 (4) (2024)
John R Cashman, Emily A Cashman
Effect of PAWI-2 on pancreatic cancer stem cell tumors. Investigational new drugs (2024)
Jorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, Wesley L McKeithan, Mark Mercola, John R Cashman
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs. Pharmacology research & perspectives 9 (4) (2022)
John R Cashman, Daniel Ryan, Wesley L McKeithan, Karl Okolotowicz, Jorge Gomez-Galeno, Mark Johnson, Kevin J Sampson, Robert S Kass, Arash Pezhouman, Hrayr S Karagueuzian, Mark Mercola
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes. Journal of medicinal chemistry 64 (9) (2021)
Jiongjia Cheng, Stephanie Moore, Jorge Gomez-Galeno, Dong-Hoon Lee, Karl J Okolotowicz, John R Cashman
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer. The Journal of pharmacology and experimental therapeutics 371 (3) (2019)
John R Cashman, Mark Gohdes, Annelies de Kater, Grant Schoenhard
N-Oxygenation of Oxycodone and Retro-reduction of Oxycodone N-Oxide. Drug metabolism and disposition: the biological fate of chemicals 48 (2) (2019)